Documentos relacionados

1. Through the heart and beyond: a review on ranolazine.
2. Considering Ranolazine as a Potential Treatment for K⁺ Channel Linked Short QT Syndrome.
3. Considering Ranolazine as a Potential Treatment for K⁺ Channel Linked Short QT Syndrome.
4. Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention.
5. The Role of Ranolazine in Heart Failure-Current Concepts.
6. [Determination of residual solvents in ranolazine by headspace gas chromatography].
7. [Analysis of primary metabolites of ranolazine in dog urine by LC-MS(n)].
8. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial.
9. Validated liquid chromatography mass spectrometry method for quantitative determination of strictosamide in dog plasma and its application to pharmacokinetic study.
10. Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.